Summary
Becton Dickinson & Co. (BDX) filed its quarterly report for the period ending June 29, 1994. The filing provides an overview of the company's financial performance during the quarter, crucial for investors to assess its operational health and market position. As this is a historical filing from 1994, it offers a snapshot of the company's standing in the mid-1990s medical technology landscape. Investors would look to this report to understand revenue trends, profitability, and any significant business developments or challenges the company was facing at that time. While the specific financial figures and detailed operational commentary are not present in the provided snippet, a comprehensive 10-Q filing typically includes detailed financial statements (balance sheets, income statements, cash flow statements), management's discussion and analysis of financial condition and results of operations, and disclosures on legal proceedings or significant accounting policies. Investors would scrutinize these sections for insights into the company's growth trajectory, its ability to manage costs, its liquidity, and any potential risks or opportunities.
Key Highlights
- 1The report covers the financial performance of Becton Dickinson & Co. (BDX) for the quarter ending June 29, 1994.
- 2The filing was made on August 11, 1994, indicating a timely reporting of quarterly results.
- 3This is a 10-Q filing, which is a standard quarterly report required by the SEC for publicly traded companies.
- 4The provided text is a directory listing from the SEC's EDGAR database, indicating the location of the full filing documents.
- 5Investors can access the complete 10-Q filing, including financial statements and management's discussion, through the EDGAR system.
- 6This historical filing provides a glimpse into BDX's financial standing during the mid-1990s.
- 7Understanding historical filings like this can be useful for long-term trend analysis and comparative studies.